Hematology Analyzers & Reagents Market Size, Share, Growth and Industry analysis, By Type (3- & 5-Part Hematology Analyzers, Point-of-Care, Fully Automated, Others), By Application (Internal Medicine, Pediatrics, Oncology) and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW

The global hematology analyzers & reagents market size was valued at USD 5.84 billion in 2025 and is expected to reach USD 11.21 billion by 2034, growing at a compound annual growth rate (CAGR) of about 7.52% from 2025 to 2034.

The United States Hematology Analyzers & Reagents Market size is projected at USD 1.99 Billion in 2025, the Europe Hematology Analyzers & Reagents Market size is projected at USD 1.71 Billion in 2025, and the China Hematology Analyzers & Reagents Market size is projected at USD 1.33 Billion in 2025.

Hematology analyzers are commonly used to count and characterize blood cells for illness identification and monitoring in patient and research settings. Basic analyzers provide a three-part differential white blood cell (WBC) count along with a complete blood count (CBC). To identify uncommon blood disorders, sophisticated analyzers can identify small cell populations and evaluate cell morphology. Hematology analyzers primarily employ three physical technologies: electrical impedance, flow cytometry, and fluorescent flow cytometry. To increase the measurable parameters, these are combined with chemical reagents that lyse or modify blood cells.

Due to the rising demand for technologically advanced and complex equipment in hospitals and research institutions, the high-end hematology analyzers sector is anticipated to grow at the highest CAGR during the forecast period. Additionally, the expansion of the low-end hematology analyzers sector is anticipated to be fueled by the rising incidence of blood cancer. Blood cells and plasma are examined using hematology analyzers and reagents. The tests aid in the diagnosis and treatment of conditions like anemia, leukemia, lymphoma, and other cancers.

KEY FINDINGS

• Market Size and Growth: The hematology analyzers and reagents market grew over 28% in usage volume globally in the last three years.
• Key Market Driver: Rising prevalence of blood disorders contributes to over 35% increased demand for diagnostic hematology devices worldwide.
• Major Market Restraint: Lack of skilled laboratory technicians affects over 22% of adoption rates, especially in low-income healthcare settings.
• Emerging Trends: AI-based hematology analyzers accounted for over 30% rise in new device installations in clinical labs globally.
• Regional Leadership: North America held over 38% of the market share, followed closely by Europe at approximately 26%.
• Competitive Landscape: Top five players together control more than 55% of the global market, intensifying R&D-based product launches.
• Market Segmentation: 3- & 5-Part Analyzers led with over 42%, while Point-of-Care segment showed growth of more than 33% recently.
• Recent Development: Fully automated hematology systems grew by over 36% in hospital labs, driven by automation and throughput efficiency.

COVID-19 IMPACT

Disruption in Supply Networks to Hinder Market Growth

Covid-19 has had a dramatic impact on enterprises, markets, and industries all around the world, but it has been especially pronounced in the medical device industry. Although the pandemic has had a largely negative influence in many industries, the MedTech sector has seen ups and downs during the crisis. PPE (personal protective equipment), ventilators, and testing kits have seen dramatically increasing demand, which has led to shortages of these products, forcing businesses to work tirelessly to keep up with the continuously expanding demands of healthcare practitioners. As other industries come to a halt, those in the business have been forced to uproot much of their typical supply networks, and lockdown protocols around the world have altered how the

LATEST TRENDS

Demand For Cutting-Edge Diagnostic Tools to Augment Market Growth

Increased public awareness of blood problems and increased demand worldwide for cutting-edge diagnostic tools. Over the coming few years, it is also anticipated that increasing investments by top healthcare providers in this region will fuel market expansion. However, it is anticipated to grow at a faster rate than other regions over the next few years because to the high unmet demands and rising opportunities in this region.

• According to the U.S. National Institutes of Health (NIH), AI-assisted hematology tools reduced manual smear review rates by over 45%, especially in low white blood cell count cases, improving diagnostic efficiency and accuracy.

• Based on European Hematology Association reports, installations of compact hematology analyzers in secondary care hospitals increased by 32% in 2023, with demand rising due to their portability and fast throughput of up to 80 samples/hour.

Request a Free sample to learn more about this report

HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION

By Type

Based on type market is classified as3- & 5-Part Hematology Analyzers, Point-of-Care, Fully Automated, Others

By Application

Based on application market is classified as Internal Medicine, Pediatrics, Oncology

DRIVING FACTORS

Hospital Segment to Provide Impetus to The Market

In terms of revenue and share, the hospital segment dominated the world market. This high percentage can be attributed to the rising incidence of blood disorders that call for ongoing observation and care and have led to an increase in the number of installations at hospitals around the world. Over the course of the forecast period, the scientific research institutions category is anticipated to increase more quickly than hospitals. This is because there is a growing need for premium haematology analysers for use in research and development projects. Due to their potential use in treating numerous blood problems, other application segments, like hospitals and clinics, are also expanding quickly.

• According to WHO, anemia affects over 1.62 billion people globally, with over 30% of pregnant women and 42% of children under five impacted, driving hospitals to invest heavily in advanced hematology testing instruments.

• As per the Indian Ministry of Health and Family Welfare, over 7,500 new diagnostic labs were established under the Ayushman Bharat program in 2023 alone, boosting demand for hematology analyzers across rural and tier-2 markets.

Improved Accuracy of the Analysers to Propel Market Growth

High-end hematology analysers are devices that examine blood for a variety of reasons. Blood illnesses are diagnosed and treated using high-end hematology analysers. They have the newest features and technology, which improves their accuracy and efficiency. Hospitals and academic research centres make use of them. Blood illnesses are diagnosed and treated with low-end haematology analysers. Haematology analysers are among them; these devices check the levels of haemoglobin, white blood cells, red blood cells, and platelets, among other things.

RESTRAINING FACTORS

Red Cells with Abnormal Forms to Impede Market Growth

The manual evaluation of a blood smear is labour-intensive and required for flagging a laboratory test result. Red cell morphological comments cannot be produced. Red cells with abnormal forms (like broken cells) cannot be identified. results that have been artificially boosted or lowered owing to outside influences. It is pricey and has substantial operating expenses.

• According to the African Society for Laboratory Medicine, only 21% of public hospitals in sub-Saharan Africa have access to automated hematology analyzers due to setup costs exceeding USD 12,000 per unit.

• Based on the U.S. Bureau of Labor Statistics, the healthcare system faced a 9.5% shortfall in certified lab technologists in 2023, affecting usage of complex multi-parameter analyzers that require precise calibration and manual oversight.

• Request a Free sample to learn more about this report

•  

HEMATOLOGY ANALYZERS AND REAGENTS MARKET REGIONAL INSIGHTS

North America to Dominate the Market Due to Existence of a Well-Established Healthcare Infrastructure

By revenue share, North America led the world market. Its huge share can be attributed to a number of factors, including the existence of a well-established healthcare infrastructure, the high adoption rate of cutting-edge diagnostic technology, and the rising prevalence of blood disorders. Additionally, it is anticipated that over the course of the forecast period, an increase in the number of research studies on hematology analysers will fuel regional demand. During the projected period, the global hematology analysers market is anticipated to develop at the quickest rate in Europe. Rising awareness of blood disorders and rising need for cutting-edge diagnostic tools are two major drivers propelling this market in the area.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Sinnowa's SN-6000A analyzer achieved a processing capacity of 60 tests/hour, enabling hospitals to manage over 450 CBCs/day, especially in urban diagnostic centers across China.

• Mindray’s BC-700 Series has over 12,000 units deployed globally and offers 9 parameters with a throughput of 80 samples/hour, widely adopted in Latin American hospital chains.

List of Top Hematology Analyzers and Reagents Companies

• Sinnowa
• Mindray
• Beckman Coulter
• Perlong
• Nihon Kohden
• Abbott Laboratories
• Drucker
• Bio-Rad
• Siemens
• Mexcom
• Tecom Science
• Sysmex
• Desco Medical
• HORIBA

REPORT COVERAGE

The report anticipates a detailed analysis of the global market size at the regional and national level, the ssegmentation market growth and market share. The prime objective of the report is to help user understand the market in terms of definition, market potential, influencing trends, and the challenges faced by the market. Aanalysis of sales, the impact of the market players, recent developments, opportunity analysis, strategic market growth analysis, territorial market expansion, and technological innovations are the subject matter explained in the report.